Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Pfizer
Age
18–90
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Male or female of any race, \>18 years of age and have BMI ≤39 kg/m2
Present with duration of chronic low back pain of ≥3 months requiring regular use of analgesic medication (\>4 days per week for the past month)
Primary location of low back pain is between the 12th thoracic vertebra and the lower gluteal folds, with or without radiation into the posterior thigh, classified as Category 1 or 2 according to the classification of the Quebec Task Force in Spinal Disorders
Must have a score of ≥4 for Low Back Pain Intensity (NRS) while on current treatment at Screening, and completes at least 4 daily pain diaries during the 5 days prior to Randomization, with an average Low Back Pain Intensity (NRS) score of ≥4
You may not be if
Back pain due to visceral disorder (i.e. endometriosis) or Back pain due to recent major trauma (i.e. vertebral fracture, post-traumatic spondylolisthesis)
History of lumbosacral radiculopathy, spinal stenosis associated with neurological impairment, or neurogenic claudication
Osteoporotic compression fracture within the last 6 months
Known history of: Rheumatoid arthritis; Seronegative spondyloarthropathy (i.e., ankylosing spondylitis, psoriatic arthritis, reactive arthritis, inflammatory bowel disease-related arthropathy); Paget's disease of spine, pelvis or femur; Fibromyalgia; Tumors or infections of the spinal cord
Patients receiving acetaminophen only to manage their chronic low back pain
Any uncontrolled or untreated chronic disease
Clareo Health | RN624 In Adult Patients With Chronic Low Back Pain
